Immedica Pharma AB
Immedica Pharma AB
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Double-blind, Randomized, Placebo-controlled Trial of Ganaxolone in CDKL5 Deficiency Patients 6 Months to Less Than 2 Years Old | CDKL5 Deficiency Disorder | Not yet recruiting | Phase 3 | 2026-08-05 | NCT05249556 |